ARCHIVES

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Three Studies Test Oncotype DX In Breast and Colon Cancers

October 26, 2012

AACR President Kripke Calls For Dedicated Translational Research

March 11, 1994

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

August 6, 2010

NCAB Approved NTP Transfer To NIEHS But Without Much Enthusiasm

May 30, 1980

Some Of Show’s Screening Messages Not Widely Accepted.

September 12, 2008

NCI-Approved Clinical Trials

July 30, 2010